http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012016139-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5a35f1bccac8690e3fe5caf89045030
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_391833b4dd32ec864f2006c829eb50c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63c0d66b5ffbd48d3d7a1934ae36e965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef1f81f2a8c9e9c3f9b47af58d14b3c9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
filingDate 2011-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_314e3eed03eccf90f3951805706f0a50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2791521719fe9629678ae06294dc093f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81085b7b9209ca06b6835962ac4eec73
publicationDate 2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012016139-A3
titleOfInvention Sirna compositions and methods for treatment of hpv and other infections
abstract The invention provides siRNA compositions that (1) interfere with viral replication of human papillomavirus (HPV), herpes simplex virus (HSV), and human immunodeficiency virus (HIV) in mucosal tissues, such as genital tissues, and (2) treat fungal infections. The compositions include siRNA molecules that target HPV, complexed with a dendrimer that treats and prevents genital herpes (HSV) and HIV. The compositions also include siRNA molecules that target HPV, complexed with a histidine-lysine (HK) polymer that treats and prevent fungus infection. The combined formulations of siRNA and dendrimer provide treatment of the infections from HPVs, HSVs, and HIVs. The combined formulations of siRNA and HK polymer provide treatment of HPVs and fungus infections.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9227956-B2
priorityDate 2010-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008287385-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010062051-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009247607-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960

Total number of triples: 26.